4//SEC Filing
Stewart Richard Alistair 4
Accession 0001209191-23-025383
CIK 0000949858other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:15 PM ET
Size
11.0 KB
Accession
0001209191-23-025383
Insider Transaction Report
Form 4
Stewart Richard Alistair
DirectorChieve Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2023-04-21+22,500→ 35,876 total - Tax Payment
Common Stock
2023-04-21$6.80/sh−10,125$68,850→ 25,751 total - Exercise/Conversion
Performance Restricted Stock Unit (PRSU)
2023-04-21+22,500→ 22,500 totalExp: 2026-01-03→ Common Stock (22,500 underlying)
Holdings
- 882(indirect: By Ricanto Limited)
Common Stock
- 359(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
- [F2]Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs.
- [F3]The reporting holder is a principal owner of Ricanto Limited.
- [F4]Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
- [F5]Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.
Documents
Issuer
ACHIEVE LIFE SCIENCES, INC.
CIK 0000949858
Entity typeother
Related Parties
1- filerCIK 0001713369
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:15 PM ET
- Size
- 11.0 KB